Effect of a Ghrelin Receptor Agonist on Muscle and Bone
Status:
Suspended
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
Adults with low muscle mass also usually have low bone mass, making them vulnerable to falls,
fractures and other injuries. This project will determine the effectiveness of treatment with
a ghrelin receptor agonist in improving short term indicators of muscle and bone health in
adults with low bone and muscle mass. The results of this trial will inform the design of a
larger, definitive randomized trial designed to establish efficacy.
Phase:
Phase 1
Details
Lead Sponsor:
Tufts University
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)